×

Exclusive-Healthcare software firm Waystar explores options including sale, sources say

By Thomson Reuters Sep 15, 2026 | 5:05 AM

By Isla Binnie, Sabrina Valle and Milana Vinn

NEW YORK, Sept 15 (Reuters) – Software provider Waystar, whose products are used by hospitals and doctors to manage payments, is exploring options including a ​potential sale that could return it to private hands two ‌years after a stock market listing in New York, seven sources familiar with the matter said.

The Lehi, Utah, and Louisville, Kentucky-based company has hired investment bank Evercore to advise on the process, which is currently at an early stage, two of the people ‌said, ​speaking on condition of anonymity to discuss confidential ⁠information. The plans could change ⁠and a sale may not materialize, they cautioned.

Waystar declined to comment. Evercore did not immediately respond to a request for comment.

Waystar’s market value has fallen to roughly $4.8 billion after a 24% slide in its ​share price this year amid a broader selloff in the software sector.

An auction process could gauge whether investor appetite for software businesses is ⁠returning.

Waystar sought to position itself as ⁠a healthcare software company, selling technology to automate and manage ​administrative work, rather than as a healthcare services business that relies more ​heavily on people to perform those tasks. The strategy aimed ‌to win the higher valuations typically afforded to technology companies.

Investors initially embraced the story, helping drive the shares from $20 to a 2025 peak of $45, but the stock later came under pressure as investors grew concerned that advances ⁠in artificial intelligence could disrupt software companies, Morgan Stanley analysts said in a report in July.

Waystar was formed in a 2017 merger between healthcare revenue ⁠management companies Zirmed and ‌Navicure. Its biggest backers, buyout firm EQT, the Canada ⁠Pension Plan Investment Board and alternative investment firm Bain ​Capital, ‌took it public in 2024.

EQT remains the company’s largest ​shareholder with ⁠a 13% stake, followed by CPPIB with 10% and BlackRock Institutional Trust Company with 8%, according to LSEG data.

EQT declined to comment. CPPIB did not immediately respond to a request for comment. BlackRock declined to comment.

(Reporting by Isla Binnie, Sabrina Valle, and Milana Vinn in New York; Editing by Echo Wang ​and Chris Reese)